Johnson & Johnson (NYSE: JNJ) established initial surge of 1.25% at $202.51, as the Stock market unbolted on Wednesday, before settling in for the price of $200.0 at the close. Taking a more long-term approach, JNJ posted a 52-week range of $140.68-$200.30.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 0.55%. Meanwhile, its Annual Earning per share during the time was 0.55%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 8.86%. This publicly-traded company’s shares outstanding now amounts to $2.41 billion, simultaneously with a float of $2.41 billion. The organization now has a market capitalization sitting at $487.91 billion. At the time of writing, stock’s 50-day Moving Average stood at $187.26, while the 200-day Moving Average is $167.57.
Johnson & Johnson (JNJ) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Johnson & Johnson industry. Johnson & Johnson’s current insider ownership accounts for 0.15%, in contrast to 74.30% institutional ownership. According to the most recent insider trade that took place on Nov 12 ’25, this organization’s 10% Owner sold 1,000 shares at the rate of 10.00, making the entire transaction reach 10,000 in total value, affecting insider ownership by 4,049,898. Preceding that transaction, on Nov 06 ’25, Company’s 10% Owner sold 52,332 for 10.21, making the whole transaction’s value amount to 534,310. This particular insider is now the holder of 4,051,098 in total.
Johnson & Johnson (JNJ) Earnings and Revenue Records
Johnson & Johnson’s EPS increase for this current 12-month fiscal period is 8.86% and is forecasted to reach 11.51 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 7.45% through the next 5 years, which can be compared against the 0.55% growth it accomplished over the previous five years trading on the market.
Johnson & Johnson (NYSE: JNJ) Trading Performance Indicators
Let’s observe the current performance indicators for Johnson & Johnson (JNJ). It’s Quick Ratio in the last reported quarter now stands at 0.80. Alongside those numbers, its PE Ratio stands at $19.54, and its Beta score is 0.33. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 5.29. Similarly, its price to free cash flow for trailing twelve months is now 24.90.
In the same vein, JNJ’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 10.36, a figure that is expected to reach 2.53 in the next quarter, and analysts are predicting that it will be 11.51 at the market close of one year from today.
Technical Analysis of Johnson & Johnson (JNJ)
Now, what If we examine the latest scores posted by [Johnson & Johnson, JNJ]. During the last 5-days, its volume was better the volume of 8.88 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 96.05% While, its Average True Range was 84.62.
Raw Stochastic average of Johnson & Johnson (JNJ) in the period of the previous 100 days is set at 98.09%, which indicates a major rise in contrast to 94.72% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 3.05 that was higher than 2.61 volatility it exhibited in the past 100-days period.
